Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Pfister

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2018
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental SpondyloarthritisMelissa N van Tok, Leonie M van Duivenvoorde, Ina Kramer, et al.
JCI Insight|February 14, 2020
Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosisFernanda do Valle Duraes, Armelle Lafont, Martin Beibel, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2018
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental SpondyloarthritisMelissa N van Tok, Leonie M van Duivenvoorde, Ina Kramer, et al.
JCI Insight|February 14, 2020
Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosisFernanda do Valle Duraes, Armelle Lafont, Martin Beibel, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Pageof 2